Consider two firms, both "technology-driven." One is newer and smaller but growing rapidly (a biotech company for example) and the other is older, larger, and more established (an integrated pharmaceutical company for example.) Do you expect their capital budgeting processes to be different? In what ways? What similarities do you expect to see?